Active Ingredient Ustekinumab

Active Ingredient Details

What is Ustekinumab?

A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies.

What is the usage for Ustekinumab?

Ustekinumab is used to treat plaque psoriasis, a certain type of arthritis (psoriatic arthritis), or certain bowel conditions (Crohn's disease, ulcerative colitis). It works by blocking certain natural proteins in your body (interleukin-12 and interleukin-23) that cause inflammation (swelling) in these conditions. Ustekinumab does not cure these diseases, but helps to lessen symptoms of the disease. It can help to decrease the amount of plaques in plaque psoriasis, decrease the number of swollen/painful joints in psoriatic arthritis, and decrease symptoms such as abdominal pain/cramping and diarrhea in Crohn's disease and ulcerative colitis.

How many products in the NDC database contain Ustekinumab?

The NDC database has 45 products with the active ingredient Ustekinumab. The following table lists all the products that have this active ingredient.

NDC Products with Ustekinumab

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
51407-929Proprietary Name: Imuldosa Ustekinumab-srlfInjectionSubcutaneousGolden State Medical Supply, Inc.ACTIVE
51407-930Proprietary Name: Imuldosa Ustekinumab-srlfInjectionSubcutaneousGolden State Medical Supply, Inc.ACTIVE
51407-931Proprietary Name: Imuldosa Ustekinumab-srlfInjectionIntravenousGolden State Medical Supply, Inc.ACTIVE
57894-054Proprietary Name: Stelara UstekinumabSolutionIntravenousJanssen Biotech, Inc.ACTIVE
57894-060Proprietary Name: Stelara UstekinumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-061Proprietary Name: Stelara UstekinumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-440Proprietary Name: Ustekinumab UstekinumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-441Proprietary Name: Ustekinumab UstekinumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-444Proprietary Name: Ustekinumab UstekinumabSolutionIntravenousJanssen Biotech, Inc.ACTIVE
61314-651Proprietary Name: Pyzchiva Ustekinumab-ttweInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-652Proprietary Name: Pyzchiva Ustekinumab-ttweInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-654Proprietary Name: Pyzchiva Ustekinumab-ttweInjection, SolutionIntravenousSandoz IncACTIVE
64538-824Proprietary Name: Ustekinumab-aauzInjectionRentschler Biopharma SeACTIVE
65219-824Proprietary Name: Otulfi Ustekinumab-aauzInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-826Proprietary Name: Otulfi Ustekinumab-aauzInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-828Proprietary Name: Otulfi Ustekinumab-aauzSolutionIntravenousFresenius Kabi Usa, LlcACTIVE
65267-896Proprietary Name: UstekinumabInjectionJanssen Pharmaceutical Sciences Unlimited CompanyACTIVE
68225-250Proprietary Name: Ustekinumab-ttweInjection, SolutionPatheon Italia S.p.aACTIVE
68225-251Proprietary Name: Ustekinumab-ttweInjection, SolutionPatheon Italia S.p.aACTIVE
68225-253Proprietary Name: Ustekinumab-ttweInjection, SolutionPatheon Italia S.p.aACTIVE
69448-017Proprietary Name: Imuldosa Ustekinumab-srlfInjectionSubcutaneousAccord Biopharma Inc.ACTIVE
69448-018Proprietary Name: Imuldosa Ustekinumab-srlfInjectionSubcutaneousAccord Biopharma Inc.ACTIVE
69448-019Proprietary Name: Imuldosa Ustekinumab-srlfInjectionIntravenousAccord Biopharma Inc.ACTIVE
70383-130Proprietary Name: UstekinumabInjection, Solution, ConcentrateBioconnection B.v.ACTIVE
72606-027Proprietary Name: Steqeyma Ustekinumab-stbaInjection, SolutionSubcutaneousCelltrion Inc.ACTIVE
72606-028Proprietary Name: Steqeyma Ustekinumab-stbaInjection, SolutionSubcutaneousCelltrion Inc.ACTIVE
72606-029Proprietary Name: Steqeyma Ustekinumab-stbaInjection, SolutionIntravenousCelltrion Inc.ACTIVE
82009-160Proprietary Name: Ustekinumab-ttwe Ustekinumab-ttweInjection, SolutionSubcutaneousQuallent Pharmaceuticals Health LlcACTIVE
82009-162Proprietary Name: Ustekinumab-ttwe Ustekinumab-ttweInjection, SolutionSubcutaneousQuallent Pharmaceuticals Health LlcACTIVE
82009-163Proprietary Name: Ustekinumab-ttwe Ustekinumab-ttweInjection, SolutionIntravenousQuallent Pharmaceuticals Health LlcACTIVE
82507-004Proprietary Name: UstekinumabSolutionAgc Biologics A/sACTIVE
83257-023Proprietary Name: Yesintek UstekinumabInjection, SolutionSubcutaneousBiocon Biologics Inc.ACTIVE
83257-024Proprietary Name: Yesintek UstekinumabInjection, SolutionSubcutaneousBiocon Biologics Inc.ACTIVE
83257-025Proprietary Name: Yesintek UstekinumabInjection, SolutionSubcutaneousBiocon Biologics Inc.ACTIVE
83257-026Proprietary Name: Yesintek UstekinumabSolutionIntravenousBiocon Biologics Inc.ACTIVE
83457-651Proprietary Name: Pyzchiva Ustekinumab-ttweInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-652Proprietary Name: Pyzchiva Ustekinumab-ttweInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-654Proprietary Name: Pyzchiva Ustekinumab-ttweInjection, SolutionIntravenousCordavis LimitedACTIVE
84612-055Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-066Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionIntravenousOptum Health Solutions (ireland) LimitedACTIVE
84612-076Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-089Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-855Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-876Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-889Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
<